Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail

J Clin Pharmacol. 2005 Dec;45(12):1413-21. doi: 10.1177/0091270005280851.

Abstract

The effects of a common oral contraceptive preparation on the activity of 7 drug-metabolizing enzymes were investigated using the validated Cooperstown 5+1 Cocktail. In a randomized crossover fashion, 10 premenopausal women received caffeine, dextromethorphan, omeprazole, intravenous midazolam, and warfarin + vitamin K with and without a triphasic oral contraceptive (ethinyl estradiol 35 microg) and varying doses of daily norgestimate (0.18, 0.215, and 0.25 mg). Bioequivalence testing showed nonequivalence in drug versus no-drug treatment on the activity of drug-metabolizing enzymes (as reflected by metabolite ratios following probe drug administration); the activity of CYP1A2, CYP2C19, and NAT-2 decreased following the oral contraceptive, whereas the activity of CYP2C9 and CYP2D6 increased. No effects on xanthine oxidase or hepatic CYP3A were seen. Application of a non-parametric statistical testing approach revealed a significant difference only for CYP1A2 and CYP2C19. This triphasic oral contraceptive may have a clinically significant effect on the activity of some drug-metabolizing enzymes.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arylamine N-Acetyltransferase / metabolism*
  • Caffeine / administration & dosage
  • Caffeine / pharmacokinetics
  • Contraceptives, Oral / administration & dosage
  • Contraceptives, Oral / pharmacokinetics*
  • Cross-Over Studies
  • Cytochrome P-450 Enzyme System / genetics
  • Cytochrome P-450 Enzyme System / metabolism*
  • Dextromethorphan / administration & dosage
  • Dextromethorphan / pharmacokinetics
  • Drug Combinations
  • Drug Interactions
  • Ethinyl Estradiol / administration & dosage
  • Ethinyl Estradiol / pharmacokinetics*
  • Female
  • Genotype
  • Humans
  • Midazolam / administration & dosage
  • Midazolam / pharmacokinetics
  • Norgestrel / administration & dosage
  • Norgestrel / analogs & derivatives*
  • Norgestrel / pharmacokinetics
  • Omeprazole / administration & dosage
  • Omeprazole / pharmacokinetics
  • Therapeutic Equivalency
  • Vitamin K / administration & dosage
  • Vitamin K / pharmacokinetics
  • Warfarin / administration & dosage
  • Warfarin / pharmacokinetics
  • Xanthine Oxidase / metabolism

Substances

  • Contraceptives, Oral
  • Drug Combinations
  • norgestimate, ethinyl estradiol drug combination
  • Vitamin K
  • Caffeine
  • Norgestrel
  • Ethinyl Estradiol
  • Warfarin
  • Dextromethorphan
  • Cytochrome P-450 Enzyme System
  • Xanthine Oxidase
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human
  • Omeprazole
  • Midazolam